These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37076969)

  • 21. Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures.
    Garcia-Giralt N; Ovejero D; Grinberg D; Nogues X; Castañeda S; Balcells S; Rabionet R
    Hum Genomics; 2024 Aug; 18(1):87. PubMed ID: 39148098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical femur fractures: 81 individual personal histories.
    Schneider JP; Hinshaw WB; Su C; Solow P
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4324-8. PubMed ID: 23076349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a p.Arg708Gln variant in COL1A2 in atypical femoral fractures.
    Funck-Brentano T; Ostertag A; Debiais F; Fardellone P; Collet C; Mornet E; Cohen-Solal M
    Joint Bone Spine; 2017 Dec; 84(6):715-718. PubMed ID: 28017821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.
    Lo JC; Neugebauer RS; Ettinger B; Chandra M; Hui RL; Ott SM; Grimsrud CD; Izano MA
    BMC Musculoskelet Disord; 2020 Dec; 21(1):801. PubMed ID: 33272248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
    Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asian ethnicity is associated with atypical femur fractures in an Australian population study.
    Nguyen HH; Lakhani A; Shore-Lorenti C; Zebaze R; Vincent AJ; Milat F; Ebeling PR
    Bone; 2020 Jun; 135():115319. PubMed ID: 32179169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
    Koh JH; Myong JP; Jung SM; Lee J; Kwok SK; Park SH; Ju JH
    Arthritis Rheumatol; 2016 Jan; 68(1):77-82. PubMed ID: 26360133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.
    Black DM; Abrahamsen B; Bouxsein ML; Einhorn T; Napoli N
    Endocr Rev; 2019 Apr; 40(2):333-368. PubMed ID: 30169557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Dell R; Greene D
    Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.
    Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS
    Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment.
    Garcia-Giralt N; Roca-Ayats N; Abril JF; Martinez-Gil N; Ovejero D; Castañeda S; Nogues X; Grinberg D; Balcells S; Rabionet R
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell Types.
    Roca-Ayats N; Ng PY; Garcia-Giralt N; Falcó-Mascaró M; Cozar M; Abril JF; Quesada Gómez JM; Prieto-Alhambra D; Nogués X; Dunford JE; Russell RG; Baron R; Grinberg D; Balcells S; Díez-Pérez A
    J Bone Miner Res; 2018 Dec; 33(12):2091-2098. PubMed ID: 30184270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Setting.
    LeBlanc ES; Rosales AG; Black DM; Genant HK; Dell RM; Friess DM; Boardman DL; Bauer DC; de Papp A; Santora AC; Orwoll ES
    J Bone Miner Res; 2017 Nov; 32(11):2304-2314. PubMed ID: 28731209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
    Zhang HY; Weng HL; Li M; Zhang J
    Osteoporos Int; 2019 Nov; 30(11):2349-2354. PubMed ID: 31428823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
    Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
    J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Low Serum Alkaline Phosphatase and Hypophosphatasia in Adult Patients with Atypical Femur Fractures.
    Tsiantouli E; Biver E; Chevalley T; Petrovic R; Hannouche D; Ferrari S
    Calcif Tissue Int; 2022 Jun; 110(6):703-711. PubMed ID: 35229197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life outcomes after surgical treatment of atypical femur fractures: a multicenter retrospective cohort study.
    Spanyer J; Barber LA; Lands H; Brown A; Bouxsein M; Heng M; Yakkanti M
    JBMR Plus; 2021 Nov; 5(11):e10514. PubMed ID: 34761142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asian Ethnicity and Femoral Geometry in Atypical Femur Fractures: Independent or Interdependent Risk Factors?
    Dhanekula ND; Crouch G; Byth K; Lau SL; Kim A; Graham E; Ellis A; Clifton-Bligh RJ; Girgis CM
    JBMR Plus; 2022 Apr; 6(4):e10607. PubMed ID: 35434447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.